NURAF(NURAF)
NURAF
No analyst ratings available
No analyst price targets available for NURAF
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $906.09B | $955.93B | $1.01T | $1.10T | $1.16T |
| Low | $895.33B | $939.15B | $993.77B | $1.08T | $1.14T |
| High | $925.50B | $1.00T | $1.04T | $1.13T | $1.20T |
| EBITDA Avg | $274.13B | $298.59B | $325.69B | $349.52B | $377.63B |
| Low | $269.95B | $293.93B | $320.53B | $343.92B | $371.53B |
| High | $283.91B | $309.46B | $337.76B | $362.59B | $391.89B |
| EBIT Avg | $223.21B | $247.67B | $274.22B | $296.67B | $323.03B |
| Low | $219.03B | $243.02B | $269.06B | $291.07B | $316.93B |
| High | $232.99B | $258.55B | $286.29B | $309.74B | $337.29B |
| Net Income Avg | $131.53B | $146.32B | $162.37B | $175.95B | $191.89B |
| Low | $129.00B | $143.51B | $159.25B | $172.56B | $188.20B |
| High | $137.44B | $152.89B | $169.67B | $183.85B | $200.51B |
| EPS Avg | $229.48 | $255.29 | $283.30 | $306.98 | $334.79 |
| Low | $225.07 | $250.38 | $277.85 | $301.07 | $328.35 |
| High | $239.79 | $266.76 | $296.03 | $320.77 | $349.83 |
| Analysts (Rev / EPS) | 15 / 1 | 15 / 1 | 10 / 1 | 7 / 1 | 6 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 |
|---|---|---|---|---|---|---|---|
| Revenue Avg | $224.41B | $229.69B | $237.03B | $231.28B | $235.15B | $241.00B | $249.47B |
| Low | $221.58B | $226.08B | $233.66B | $227.99B | $231.81B | $237.58B | $245.93B |
| High | $228.87B | $234.83B | $242.04B | $236.17B | $240.12B | $246.10B | $254.74B |
| EBITDA Avg | $70.09B | $70.18B | $67.08B | $71.51B | — | — | — |
| Low | $69.06B | $69.14B | $66.09B | $70.44B | — | — | — |
| High | $71.64B | $71.73B | $68.54B | $73.09B | — | — | — |
| EBIT Avg | $57.34B | $57.46B | $54.36B | $58.81B | — | — | — |
| Low | $56.30B | $56.41B | $53.37B | $57.74B | — | — | — |
| High | $58.89B | $59.00B | $55.82B | $60.39B | — | — | — |
| Net Income Avg | $34.03B | $34.10B | $32.23B | $34.92B | — | — | — |
| Low | $33.40B | $33.47B | $31.63B | $34.27B | — | — | — |
| High | $34.97B | $35.04B | $33.11B | $35.88B | — | — | — |
| EPS Avg | $59.90 | $60.02 | $56.72 | $61.46 | — | — | — |
| Low | $58.79 | $58.91 | $55.67 | $60.32 | — | — | — |
| High | $61.55 | $61.67 | $58.28 | $63.15 | — | — | — |
| Analysts (Rev / EPS) | 8 / 1 | 8 / 1 | 4 / 1 | 5 / 1 | 4 / — | 5 / — | 3 / — |